Cochlear Investor Relations Material
Latest events
H2 2025
Cochlear
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cochlear Limited
Access all reports
Cochlear Limited is an Australia-based medical device company specializing in implantable hearing solutions. The company designs, manufactures, and distributes cochlear implants, bone conduction systems, and acoustic implants, providing solutions for individuals with moderate to profound hearing loss. Cochlear also offers a range of services and accessories to support patients and healthcare professionals throughout the hearing restoration process.
Key slides for Cochlear Limited
H2 2025
Cochlear Limited
H2 2025
Cochlear Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
COH
Country
🇦🇺 Australia